Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

NMR evidence of charge‐dependent interaction between various PND V3 and CCR5 N‐terminal peptides

Identifieur interne : 002873 ( Main/Exploration ); précédent : 002872; suivant : 002874

NMR evidence of charge‐dependent interaction between various PND V3 and CCR5 N‐terminal peptides

Auteurs : Petros A. Galanakis [Grèce] ; Nikolaos G. Kandias [Grèce] ; Apostolos K. Rizos [Grèce] ; Dimitrios Morikis [États-Unis] ; Elias Krambovitis [Grèce] ; Georgios A. Spyroulias [Grèce]

Source :

RBID : ISTEX:C80F6FAC42DE29596B60CFD92F3DB04294859B3B

English descriptors

Abstract

The third variable (V3) loop is an important region of glycoprotein 120 (gp120) for many biological processes, as it contains the highly conserved GPGR sequence and it represents the binding site for human immunodeficiency virus 1 (HIV‐1) antibodies and for CCR5 and CXCR4 host cell coreceptors. The interaction of the principal neutralizing determinant (PND) V3 with the chemokine receptor CCR5 N‐terminal region has been reported to be crucial for HIV‐1 infection. The goal of this study is to characterize the solution structures of three HIV‐1 gp120 V3 subtype B peptides and their interaction with a nonsulfated N‐terminal CCR5 peptide. NMR titration experiments revealed that the CCR5Nt‐PND V3 interaction is dependent on the number of the positively charged V3 residues, which is in agreement with the observation that increase in positive charge in the V3 sequence correlates with the augmentation of the interaction. As expected for free peptides in solution, the peptides representing the PND V3 region of gp120 exhibit conformational flexibility, but they also exhibit a large number of NOEs which allowed convergence to a dominant conformation. The PND V3 peptides retain the U‐turn conformation observed in the crystal structures of gp120 complexes independently of CCR5 presence. The interaction of different regions of the CCR5Nt peptide is gradually increasing proportionally to the positive charge increase in the V3 peptides. The data demonstrate that the PND V3 and CCR5Nt peptide sequences have propensities for interaction even in the absence of sulfated tyrosines and that their binding and selectivity is determined by simple electrostatic attraction mechanisms. © 2008 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 92: 94–109, 2009. This article was originally published online as an accepted preprint. The “Published Online” date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at biopolymers@wiley.com

Url:
DOI: 10.1002/bip.21127


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">NMR evidence of charge‐dependent interaction between various PND V3 and CCR5 N‐terminal peptides</title>
<author>
<name sortKey="Galanakis, Petros A" sort="Galanakis, Petros A" uniqKey="Galanakis P" first="Petros A." last="Galanakis">Petros A. Galanakis</name>
</author>
<author>
<name sortKey="Kandias, Nikolaos G" sort="Kandias, Nikolaos G" uniqKey="Kandias N" first="Nikolaos G." last="Kandias">Nikolaos G. Kandias</name>
</author>
<author>
<name sortKey="Rizos, Apostolos K" sort="Rizos, Apostolos K" uniqKey="Rizos A" first="Apostolos K." last="Rizos">Apostolos K. Rizos</name>
</author>
<author>
<name sortKey="Morikis, Dimitrios" sort="Morikis, Dimitrios" uniqKey="Morikis D" first="Dimitrios" last="Morikis">Dimitrios Morikis</name>
</author>
<author>
<name sortKey="Krambovitis, Elias" sort="Krambovitis, Elias" uniqKey="Krambovitis E" first="Elias" last="Krambovitis">Elias Krambovitis</name>
</author>
<author>
<name sortKey="Spyroulias, Georgios A" sort="Spyroulias, Georgios A" uniqKey="Spyroulias G" first="Georgios A." last="Spyroulias">Georgios A. Spyroulias</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C80F6FAC42DE29596B60CFD92F3DB04294859B3B</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1002/bip.21127</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-BK21N2D4-2/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C41</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001C41</idno>
<idno type="wicri:Area/Istex/Curation">001C41</idno>
<idno type="wicri:Area/Istex/Checkpoint">000670</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000670</idno>
<idno type="wicri:doubleKey">0006-3525:2009:Galanakis P:nmr:evidence:of</idno>
<idno type="wicri:Area/Main/Merge">002899</idno>
<idno type="wicri:Area/Main/Curation">002873</idno>
<idno type="wicri:Area/Main/Exploration">002873</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">NMR evidence of charge‐dependent interaction between various PND V3 and CCR5 N‐terminal peptides</title>
<author>
<name sortKey="Galanakis, Petros A" sort="Galanakis, Petros A" uniqKey="Galanakis P" first="Petros A." last="Galanakis">Petros A. Galanakis</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pharmacy, University of Patras, Panepistimioupoli—Rion, GR‐26504, Patras</wicri:regionArea>
<wicri:noRegion>Patras</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kandias, Nikolaos G" sort="Kandias, Nikolaos G" uniqKey="Kandias N" first="Nikolaos G." last="Kandias">Nikolaos G. Kandias</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pharmacy, University of Patras, Panepistimioupoli—Rion, GR‐26504, Patras</wicri:regionArea>
<wicri:noRegion>Patras</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rizos, Apostolos K" sort="Rizos, Apostolos K" uniqKey="Rizos A" first="Apostolos K." last="Rizos">Apostolos K. Rizos</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Chemistry, University of Crete and Foundation for Research and Technology‐Hellas, FORTH‐IESL, GR‐71003, Heraklion, Crete</wicri:regionArea>
<wicri:noRegion>Crete</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Morikis, Dimitrios" sort="Morikis, Dimitrios" uniqKey="Morikis D" first="Dimitrios" last="Morikis">Dimitrios Morikis</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Bioengineering, University of California, Riverside</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Krambovitis, Elias" sort="Krambovitis, Elias" uniqKey="Krambovitis E" first="Elias" last="Krambovitis">Elias Krambovitis</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Applied Immunology, Institute of Molecular Biology and Biotechnology, FORTH, GR‐71110, Heraklion, Crete</wicri:regionArea>
<wicri:noRegion>Crete</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Veterinary Medicine, University of Thessaly, Karditsa</wicri:regionArea>
<wicri:noRegion>Karditsa</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Grèce</country>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Elias Krambovitis, Department of Applied Immunology, Institute of Molecular Biology and Biotechnology, FORTH, GR‐71110, Heraklion, Crete, GreeceGeorgios A. Spyroulias, Department of Pharmacy, University of Patras, Panepistimioupoli—Rion, GR‐26504, Patras</wicri:regionArea>
<wicri:noRegion>Patras</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Spyroulias, Georgios A" sort="Spyroulias, Georgios A" uniqKey="Spyroulias G" first="Georgios A." last="Spyroulias">Georgios A. Spyroulias</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pharmacy, University of Patras, Panepistimioupoli—Rion, GR‐26504, Patras</wicri:regionArea>
<wicri:noRegion>Patras</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Grèce</country>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Elias Krambovitis, Department of Applied Immunology, Institute of Molecular Biology and Biotechnology, FORTH, GR‐71110, Heraklion, Crete, GreeceGeorgios A. Spyroulias, Department of Pharmacy, University of Patras, Panepistimioupoli—Rion, GR‐26504, Patras</wicri:regionArea>
<wicri:noRegion>Patras</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Peptide Science</title>
<title level="j" type="alt">PEPTIDE SCIENCE</title>
<idno type="ISSN">0006-3525</idno>
<idno type="eISSN">1097-0282</idno>
<imprint>
<biblScope unit="vol">92</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="94">94</biblScope>
<biblScope unit="page" to="109">109</biblScope>
<biblScope unit="page-count">16</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2009">2009</date>
</imprint>
<idno type="ISSN">0006-3525</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-3525</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Amino</term>
<term>Amino acid</term>
<term>Amino acids</term>
<term>Anglister</term>
<term>Aromatic ring</term>
<term>Asp2</term>
<term>Biochem biophys</term>
<term>Biol</term>
<term>Biophys</term>
<term>Biopolymers</term>
<term>Ccr5</term>
<term>Ccr5nt</term>
<term>Ccr5nt peptide</term>
<term>Ccr5nt presence</term>
<term>Chem</term>
<term>Chemical shift changes</term>
<term>Chemical shift charts</term>
<term>Chemical shift differentiation plots</term>
<term>Conformation</term>
<term>Conformational changes</term>
<term>Connectivity</term>
<term>Electrostatic potentials</term>
<term>Experimental data</term>
<term>Galanakis</term>
<term>Gly7</term>
<term>Gly7 met1</term>
<term>Gly9</term>
<term>Gpgr</term>
<term>Gpgr segment</term>
<term>Heavy atoms</term>
<term>His5</term>
<term>Hsqc</term>
<term>Hsqc spectra</term>
<term>Ile4</term>
<term>Ile6</term>
<term>Interaction process</term>
<term>Krambovitis</term>
<term>Long range</term>
<term>Long range connectivities</term>
<term>Long range noes</term>
<term>Lys2</term>
<term>Magn reson</term>
<term>Met1</term>
<term>Noesy</term>
<term>Noesy crosspeaks</term>
<term>Noesy spectra</term>
<term>Peptide</term>
<term>Peptide interactions</term>
<term>Peptide science</term>
<term>Perturbation</term>
<term>Proc natl acad</term>
<term>Proton</term>
<term>Residue</term>
<term>Right panels</term>
<term>Sequential connectivities</term>
<term>Side chain</term>
<term>Solution structures</term>
<term>Spandidos</term>
<term>Spectral width</term>
<term>Structural calculations</term>
<term>Titration</term>
<term>Total number</term>
<term>Tyr3</term>
<term>Unique noes</term>
<term>Vast majority</term>
<term>Wuthrich</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The third variable (V3) loop is an important region of glycoprotein 120 (gp120) for many biological processes, as it contains the highly conserved GPGR sequence and it represents the binding site for human immunodeficiency virus 1 (HIV‐1) antibodies and for CCR5 and CXCR4 host cell coreceptors. The interaction of the principal neutralizing determinant (PND) V3 with the chemokine receptor CCR5 N‐terminal region has been reported to be crucial for HIV‐1 infection. The goal of this study is to characterize the solution structures of three HIV‐1 gp120 V3 subtype B peptides and their interaction with a nonsulfated N‐terminal CCR5 peptide. NMR titration experiments revealed that the CCR5Nt‐PND V3 interaction is dependent on the number of the positively charged V3 residues, which is in agreement with the observation that increase in positive charge in the V3 sequence correlates with the augmentation of the interaction. As expected for free peptides in solution, the peptides representing the PND V3 region of gp120 exhibit conformational flexibility, but they also exhibit a large number of NOEs which allowed convergence to a dominant conformation. The PND V3 peptides retain the U‐turn conformation observed in the crystal structures of gp120 complexes independently of CCR5 presence. The interaction of different regions of the CCR5Nt peptide is gradually increasing proportionally to the positive charge increase in the V3 peptides. The data demonstrate that the PND V3 and CCR5Nt peptide sequences have propensities for interaction even in the absence of sulfated tyrosines and that their binding and selectivity is determined by simple electrostatic attraction mechanisms. © 2008 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 92: 94–109, 2009. This article was originally published online as an accepted preprint. The “Published Online” date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at biopolymers@wiley.com</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Grèce</li>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
</region>
</list>
<tree>
<country name="Grèce">
<noRegion>
<name sortKey="Galanakis, Petros A" sort="Galanakis, Petros A" uniqKey="Galanakis P" first="Petros A." last="Galanakis">Petros A. Galanakis</name>
</noRegion>
<name sortKey="Kandias, Nikolaos G" sort="Kandias, Nikolaos G" uniqKey="Kandias N" first="Nikolaos G." last="Kandias">Nikolaos G. Kandias</name>
<name sortKey="Krambovitis, Elias" sort="Krambovitis, Elias" uniqKey="Krambovitis E" first="Elias" last="Krambovitis">Elias Krambovitis</name>
<name sortKey="Krambovitis, Elias" sort="Krambovitis, Elias" uniqKey="Krambovitis E" first="Elias" last="Krambovitis">Elias Krambovitis</name>
<name sortKey="Krambovitis, Elias" sort="Krambovitis, Elias" uniqKey="Krambovitis E" first="Elias" last="Krambovitis">Elias Krambovitis</name>
<name sortKey="Krambovitis, Elias" sort="Krambovitis, Elias" uniqKey="Krambovitis E" first="Elias" last="Krambovitis">Elias Krambovitis</name>
<name sortKey="Rizos, Apostolos K" sort="Rizos, Apostolos K" uniqKey="Rizos A" first="Apostolos K." last="Rizos">Apostolos K. Rizos</name>
<name sortKey="Spyroulias, Georgios A" sort="Spyroulias, Georgios A" uniqKey="Spyroulias G" first="Georgios A." last="Spyroulias">Georgios A. Spyroulias</name>
<name sortKey="Spyroulias, Georgios A" sort="Spyroulias, Georgios A" uniqKey="Spyroulias G" first="Georgios A." last="Spyroulias">Georgios A. Spyroulias</name>
<name sortKey="Spyroulias, Georgios A" sort="Spyroulias, Georgios A" uniqKey="Spyroulias G" first="Georgios A." last="Spyroulias">Georgios A. Spyroulias</name>
</country>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Morikis, Dimitrios" sort="Morikis, Dimitrios" uniqKey="Morikis D" first="Dimitrios" last="Morikis">Dimitrios Morikis</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002873 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002873 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:C80F6FAC42DE29596B60CFD92F3DB04294859B3B
   |texte=   NMR evidence of charge‐dependent interaction between various PND V3 and CCR5 N‐terminal peptides
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021